TrialDiabetologia2024

The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomised controlled trial.

Nancy S Elbarbary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.